These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19732978)

  • 21. ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy.
    Remuzzi A; Perico N; Sangalli F; Vendramin G; Moriggi M; Ruggenenti P; Remuzzi G
    Am J Physiol; 1999 Mar; 276(3):F457-66. PubMed ID: 10070170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference between electrical remodelling after pulmonary veins and right atrium appendage pacing.
    Hafid KA; Xin HC; Xi W; Yan ZQ; Bo Y
    Europace; 2007 Aug; 9(8):608-12. PubMed ID: 17630393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.
    Nakatani Y; Nishida K; Sakabe M; Kataoka N; Sakamoto T; Yamaguchi Y; Iwamoto J; Mizumaki K; Fujiki A; Inoue H
    J Am Coll Cardiol; 2013 Feb; 61(5):582-8. PubMed ID: 23273396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-(1-7) attenuates atrial tachycardia-induced sympathetic nerve remodeling.
    Shangguan W; Shi W; Li G; Wang Y; Li J; Wang X
    J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317729281. PubMed ID: 28877652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
    Blanchet M; Sheppard R; Racine N; Ducharme A; Curnier D; Tardif JC; Sirois P; Lamoureux MC; De Champlain J; White M
    Am Heart J; 2005 May; 149(5):938.e1-7. PubMed ID: 15894946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
    Coleman CI; Makanji S; Kluger J; White CM
    Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Upstream approach for atrial fibrillation].
    Kumagai K
    Nihon Yakurigaku Zasshi; 2010 Feb; 135(2):59-61. PubMed ID: 20154411
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling.
    Shinagawa K; Mitamura H; Ogawa S; Nattel S
    Cardiovasc Res; 2002 May; 54(2):438-46. PubMed ID: 12062348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study.
    Montalescot G; Drexler H; Gallo R; Pearson T; Thoenes M; Bhatt DL
    Eur Heart J; 2009 Nov; 30(22):2733-41. PubMed ID: 19700470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.
    Madrid AH; Bueno MG; Rebollo JM; Marín I; Peña G; Bernal E; Rodriguez A; Cano L; Cano JM; Cabeza P; Moro C
    Circulation; 2002 Jul; 106(3):331-6. PubMed ID: 12119249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.
    Funabiki K; Onishi K; Dohi K; Koji T; Imanaka-Yoshida K; Ito M; Wada H; Isaka N; Nobori T; Nakano T
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2487-92. PubMed ID: 15548724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
    Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
    Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
    Kalus JS; Coleman CI; White CM
    J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.
    Nakashima H; Kumagai K; Urata H; Gondo N; Ideishi M; Arakawa K
    Circulation; 2000 Jun; 101(22):2612-7. PubMed ID: 10840013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.
    Larochelle P; Flack JM; Marbury TC; Sareli P; Krieger EM; Reeves RA
    Am J Cardiol; 1997 Dec; 80(12):1613-5. PubMed ID: 9416950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients.
    Masaki M; Komamura K; Goda A; Hirotani S; Otsuka M; Nakabo A; Fukui M; Fujiwara S; Sugahara M; Lee-Kawabata M; Tsujino T; Koshiba M; Masuyama T
    J Cardiol; 2014 Mar; 63(3):205-10. PubMed ID: 24060523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease.
    Schieffer B; Bünte C; Witte J; Hoeper K; Böger RH; Schwedhelm E; Drexler H
    J Am Coll Cardiol; 2004 Jul; 44(2):362-8. PubMed ID: 15261932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-treatment with Irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation.
    Dagres N; Karatasakis G; Panou F; Athanassopoulos G; Maounis T; Tsougos E; Kourea K; Malakos I; Kremastinos DT; Cokkinos DV
    Eur Heart J; 2006 Sep; 27(17):2062-8. PubMed ID: 16891381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation.
    Yue L; Feng J; Gaspo R; Li GR; Wang Z; Nattel S
    Circ Res; 1997 Oct; 81(4):512-25. PubMed ID: 9314832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.